VR Logo

Suven Pharmaceuticals Ltd. download report


Healthcare | Drugs & Pharma

Suven Pharmaceuticals Ltd. Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2021 Suven Pharmaceuticals Ltd. Annual Report
2020 Suven Pharmaceuticals Ltd. Annual Report Suven Pharmaceuticals Ltd. chairman speech Suven Pharmaceuticals Ltd. director's report Suven Pharmaceuticals Ltd. management discussion Suven Pharmaceuticals Ltd. corporate governance Suven Pharmaceuticals Ltd. auditor's report Suven Pharmaceuticals Ltd. account notes
2019 Suven Pharmaceuticals Ltd. Annual Report Suven Pharmaceuticals Ltd. chairman speech Suven Pharmaceuticals Ltd. director's report Suven Pharmaceuticals Ltd. management discussion Suven Pharmaceuticals Ltd. corporate governance Suven Pharmaceuticals Ltd. auditor's report Suven Pharmaceuticals Ltd. account notes

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 2018

Chairman: Venkateswarlu Jasti

Managing Director: Venkateswarlu Jasti

Listing: BSE: 543064, NSE: SUVENPHAR

Country: India

Headquarters: Hyderabad, Telangana

Website: www.suvenpharm.com

Key Facts

Market cap: ₹13,209.38 Cr

Revenue (TTM): ₹1,320.22 Cr

Earnings (TTM): ₹453.81 Cr

Cash: ₹528.53 Cr

Total Debt: ₹141.23 Cr

Promoters' ownership: 60.00%

Liquidity: High

52 Week range: ₹425.70 - 631.75

Face value: ₹1.00

Shares outstanding: 25,45,64,956

Stock Performance

Time Period Suven Pharmaceuticals S&P BSE Healthcare S&P BSE Mid Cap
YTD5.29-15.06-11.62
1 month-10.38-9.88-10.82
3 months-5.79-6.60-7.16
1 Year-3.08-7.783.94
3 Years--19.0215.54
5 Years--8.358.39
10 Years--12.9014.17
As on 19-May-2022
Year Suven Pharmaceuticals S&P BSE Mid Cap S&P BSE Healthcare
20216.5739.1820.87